Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 4/21/2016 |
| Start Date: | April 2014 |
| End Date: | July 2014 |
An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study Of 40 Mg Doses Of Pf-00345439 To Evaluate The Bioequivalence Of Modified Formulation K Vs. Original Formulation X Under Intermediate-Fat Fed Conditions And To Estimate Relative Bioavailability Under Fasting Conditions In Healthy Volunteers
To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formulation K Vs.
Original Formulation X Under Fed And Fasting Conditions In Healthy Volunteers
Original Formulation X Under Fed And Fasting Conditions In Healthy Volunteers
Inclusion Criteria:
- Healthy male and/or female subjects between 18 and 55 years of age
Exclusion Criteria:
- Evidence or history of clinically significant disease.
- Positive urine drug test
We found this trial at
1
site
Click here to add this to my saved trials
